loader
Please Wait
Applying Filters...
menu
    • menu

    Technical details about Resiquimod, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Resiquimod

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 438,793Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 144875-48-9, R-848, 1-(4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol, 1-[4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol, Resiquimod [inn], R 848
    Molecular Formula
    C17H22N4O2
    Molecular Weight
    314.4  g/mol
    InChI Key
    BXNMTOQRYBFHNZ-UHFFFAOYSA-N
    FDA UNII
    V3DMU7PVXF
    Resiquimod is an imidazoquinolinamine and Toll-like receptor (TLR) agonist with potential immune response modifying activity. Resiquimod exerts its effect through the TLR signaling pathway by binding to and activating TLR7 and 8 mainly on dendritic cells, macrophages, and B-lymphocytes. This induces the nuclear translocation of the transcription activator NF-kB as well as activation of other transcription factors. This may lead to an increase in mRNA levels and subsequent production of cytokines, especially interferon-alpha (INF-a) and other cytokines, thereby enhancing T-helper 1 (Th1) immune responses. In addition, topical application of resiquimod appears to activate Langerhans' cells, leading to an enhanced activation of T-lymphocytes. Due to its immunostimulatory activity, this agent may potentially be useful as a vaccine adjuvant.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
    2.1.2 InChI
    InChI=1S/C17H22N4O2/c1-4-23-9-13-20-14-15(21(13)10-17(2,3)22)11-7-5-6-8-12(11)19-16(14)18/h5-8,22H,4,9-10H2,1-3H3,(H2,18,19)
    2.1.3 InChI Key
    BXNMTOQRYBFHNZ-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
    2.2 Other Identifiers
    2.2.1 UNII
    V3DMU7PVXF
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. R 848

    2. R-848

    3. R848 Compound

    2.3.2 Depositor-Supplied Synonyms

    1. 144875-48-9

    2. R-848

    3. 1-(4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol

    4. 1-[4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol

    5. Resiquimod [inn]

    6. R 848

    7. Resiquimod (r-848)

    8. R848

    9. S 28463

    10. S-28463

    11. V3dmu7pvxf

    12. Mfcd00937759

    13. Chembl383322

    14. Chebi:36706

    15. 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol

    16. Cd11301

    17. Cd-11301

    18. R848;s28463

    19. 2252319-44-9

    20. 1-(4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol.

    21. 1h-imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-

    22. 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol

    23. R848 Compound

    24. Unii-v3dmu7pvxf

    25. 1h-imidazo(4,5-c)quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-

    26. 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1h-imidazo(4,5-c)quinoline-1-ethanol

    27. Resiquimodr848

    28. Vml-600

    29. Rx8

    30. R848; Resiquimod

    31. S28463

    32. Resiquimod [mi]

    33. Resiquimod [usan]

    34. Resiquimod [mart.]

    35. Resiquimod [who-dd]

    36. Schembl34159

    37. Mls006010212

    38. Alpha-dimethyl-1h-imidazo(4,5-c)quinoline-1-ethanol

    39. Gtpl5051

    40. Dtxsid7040603

    41. Resiquimod, >=98% (hplc)

    42. Hms3740o09

    43. Bcp09103

    44. Ex-a1879

    45. Bdbm50241029

    46. S8133

    47. Zinc28572103

    48. Akos016003509

    49. Ccg-267635

    50. Cs-1706

    51. Db06530

    52. Sb17111

    53. 1-(4-amino-2-ethoxymethyl-imidazo[4,5-c]quinolin-1-yl)-2-methyl-propan-2-ol

    54. Ncgc00370784-01

    55. Ncgc00370784-05

    56. Ac-35716

    57. As-30885

    58. Hy-13740

    59. Smr002530531

    60. Sy107476

    61. Ft-0763049

    62. R0197

    63. Resiquimod, Vml-600, R-848, S-28463

    64. A856222

    65. Q426054

    66. Sr-01000944954

    67. J-008020

    68. Sr-01000944954-1

    69. 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methyl-propan-2-ol

    70. 4-amino-2-ethoxymethyl-alpha,alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol

    71. 4-amino-alpha,alpha-dimethyl-2-ethoxymethyl-1h-imidazo[4,5-c]quinolin-1-ethanol

    72. 4-amino-alpha,alpha-dimethyl-2-ethoxymethyl-1h-imidazo[4,5-c]quinoline-1-ethanol

    2.4 Create Date
    2005-08-01
    3 Chemical and Physical Properties
    Molecular Weight 314.4 g/mol
    Molecular Formula C17H22N4O2
    XLogP31.3
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count5
    Exact Mass314.17427596 g/mol
    Monoisotopic Mass314.17427596 g/mol
    Topological Polar Surface Area86.2 Ų
    Heavy Atom Count23
    Formal Charge0
    Complexity406
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in genital herpes.

    5 Pharmacology and Biochemistry
    5.1 Mechanism of Action

    Resiquimod is a Toll-like receptor 7 (TLR7) and TLR8 agonist that is a potent inducer of alpha interferon (IFN-alpha) and other cytokines.